Bioequivalence Study of Finasteride

    December 2011 in “ Drug Research ”
    Fabiana Gatti de Menezes, Wellington Souto Ribeiro, Demian R. Ifa, Maria Elisabete Amaral de Moraes, Manoel Odorico de Moraes, Gilberto De Nucci
    New to Finasteride? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study concluded that Flaxin tablets and the reference formulation are bioequivalent in terms of absorption rate and extent when administered as a single 5 mg dose to healthy male volunteers.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This document is a bioequivalence study of finasteride, a drug used to treat hair loss and benign prostatic hyperplasia. The study found that there were no significant differences in the rate and extent of absorption between two different formulations of finasteride, indicating bioequivalence. The method used to analyze the drug in human plasma was found to be accurate and suitable for routine analysis. The study also noted the role of hepatic metabolism and biliary excretion in the disposition of the drug.
    Discuss this study in the Community →